Satisfaction of Patients With the Chosen Method of Inhibition of Lactation

Last updated: July 26, 2019
Sponsor: Żelazna Medical Centre, LLC
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04038749
23/2019
  • Ages > 18
  • Female
  • Accepts Healthy Volunteers

Study Summary

The aim of the study is to improve the standard of care in case of the inhibition of lactation.

The participant qualified for the study will answer the questions contained in the survey. The patient will have her breast palpated and then will be instructed on the possible options for the inhibition of lactation. The participant, who decides to inhibit lactation with medications, will be consulted by a doctor.

Each patient will receive information of the possible ways to relieve the symptoms of overfilled breast and be able to contact with lactation consultant. The participant will also receive a card to assess the severity of symptoms in the following days. The investigators will call the patient between the third and fifth day by phone.

Once again, after 2 weeks from the beginning of the inhibition of lactation in order to ask questions contained in the survey (the course of the process, problems that occurred and the level of satisfaction with the chosen method).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Mother during the period of six weeks after childbirth

  • Decision to inhibit lactation

  • Patient's age at the time of enrollment (at least 18 years old)

Exclusion

Exclusion Criteria:

  • Less than 18 years of age

  • Lack of patient's consent

  • To the pharmacotherapy group- contraindications for the use of the medication

Study Design

Total Participants: 90
Study Start date:
June 16, 2019
Estimated Completion Date:
December 31, 2022

Connect with a study center

  • Żelazna Medical Centre

    Warsaw,
    Poland

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.